OCUL smart money
Ocular Therapeutix, INC (OCUL): 1 insider buy, 8 top funds holding it, 3 ETF changes in the public filings.
Insider buys, 12 months$461k
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-02-24 | Lindstrom Richard L Md | Director | $461k | $7.66 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 2 | Venrock Adviser, LLC | 3.86% | $79M | |
| 15 | Logos Global Management LP | ADD +13% | 2.78% | $46M |
| 19 | Tcg Crossover Management, LLC | TRIM -56% | 0.16% | $6M |
| 23 | Redmile Group, LLC | BUY | 0.14% | $2M |
| 24 | Orbimed Advisors LLC | 0.03% | $2M | |
| 30 | Deep Track Capital, LP | ADD +11% | 2.83% | $168M |
| 80 | Avoro Capital Advisors LLC | 0.98% | $95M | |
| 93 | Octagon Capital Advisors LP | TRIM -71% | 0.62% | $5M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| Invesco Pharmaceuticals ETF | ADD | +$3M | 2026-07-31 |
| State Street(R) Spdr(R) S&p(R) Pharmaceuticals ETF | ADD | +$1M | 2026-06-30 |
| Ishares U.S. Pharmaceuticals ETF | TRIM | −$300k | 2026-06-30 |